METTL3 and metabolic dysfunction-associated steatohepatitis: Hepatic deletion of Mettl3 promotes NASH progression under either HFD or MCD-feeding conditions due to increased hepatic free fatty acid uptake and inflammation, which are strongly associated with increased expression of Cd36 and Ccl2, respectively.